0001104659-23-060793.txt : 20230515
0001104659-23-060793.hdr.sgml : 20230515
20230515161635
ACCESSION NUMBER: 0001104659-23-060793
CONFORMED SUBMISSION TYPE: 13F-HR
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20230331
FILED AS OF DATE: 20230515
DATE AS OF CHANGE: 20230515
EFFECTIVENESS DATE: 20230515
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: VR Adviser, LLC
CENTRAL INDEX KEY: 0001615982
IRS NUMBER: 464814731
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 13F-HR
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-20281
FILM NUMBER: 23922637
BUSINESS ADDRESS:
STREET 1: 7 BRYANT PARK
STREET 2: 23RD FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10018
BUSINESS PHONE: 650-475-3734
MAIL ADDRESS:
STREET 1: 7 BRYANT PARK
STREET 2: 23RD FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10018
13F-HR
1
primary_doc.xml
X0202
13F-HR
LIVE
false
false
false
0001615982
XXXXXXXX
03-31-2023
03-31-2023
false
VR Adviser, LLC
7 BRYANT PARK
23RD FLOOR
NEW YORK
NY
10018
13F HOLDINGS REPORT
028-20281
000169288
801-79382
Y
Note: VR Adviser, LLC is filing this Form 13F on behalf of itself and the general partner entities of the investment funds for which it serves as the investment adviser, VHCP Management II, LLC, VHCP Management III, LLC, VHCP Management EG, LLC and Venrock Opportunities Management, LLC. The reporting manager's holdings of DBV Technologies S A ("DBV") equity securities as of March 31, 2023 consisted of ordinary shares, which are not considered "Section 13(f) securities" and are, therefore, not reportable on Form 13F, in contrast to American depositary shares, which are reportable on Form 13F. This Form 13F does not reflect the disposition of any securities of DBV by the reporting manager.
Sherman G. Souther
Authorized Signatory
650-561-9580
/s/ Sherman G. Souther
Palo Alto
CA
05-15-2023
0
25
512168605
INFORMATION TABLE
2
infotable.xml
ACLARIS THERAPEUTICS INC
COM
00461U105
8419700
1040754
SH
SOLE
1040754
0
0
AEROVATE THERAPEUTICS INC
COM
008064107
16820308
833927
SH
SOLE
833927
0
0
AFFIMED N V
COM
N01045108
1065143
1428571
SH
SOLE
1428571
0
0
AMBRX BIOPHARMA INC
SPONSORED ADS
02290A102
29423307
3298577
SH
SOLE
3298577
0
0
ANNEXON INC
COM
03589W102
12397193
3220050
SH
SOLE
3220050
0
0
AVALO THERAPEUTICS INC
COM NEW
05338F207
1750000
1000000
SH
SOLE
1000000
0
0
CABALETTA BIO INC
COM
12674W109
16318786
1973251
SH
SOLE
1973251
0
0
CELCUITY INC
COM
15102K100
21580207
2105386
SH
SOLE
2105386
0
0
COGENT BIOSCIENCES INC
COM
19240Q201
52708902
4884977
SH
SOLE
4884977
0
0
DICE THERAPEUTICS INC
COM
23345J104
23464350
819000
SH
SOLE
819000
0
0
ENLIVEN THERAPEUTICS INC
COM
29337E102
48489710
2214142
SH
SOLE
2214142
0
0
FULCRUM THERAPEUTICS INC
COM
359616109
3725218
1307094
SH
SOLE
1307094
0
0
GH RESEARCH PLC
ORDINARY SHARES
G3855L106
28101829
3517125
SH
SOLE
3517125
0
0
KALVISTA PHARMACEUTICALS INC
COM
483497103
22925003
2916667
SH
SOLE
2916667
0
0
LYRA THERAPEUTICS INC
COM
55234L105
1857582
924170
SH
SOLE
924170
0
0
MERUS N V
COM
N5749R100
22562338
1226214
SH
SOLE
1226214
0
0
MILESTONE PHARMACEUTICALS IN
COM
59935V107
8702719
2208812
SH
SOLE
2208812
0
0
PLIANT THERAPEUTICS INC
COM
729139105
38038000
1430000
SH
SOLE
1430000
0
0
RALLYBIO CORP
COM
75120L100
1533318
268532
SH
SOLE
268532
0
0
SAVARA INC
COM
805111101
12385485
6351531
SH
SOLE
6351531
0
0
TERNS PHARMACEUTICALS INC
COM
880881107
42855140
3619522
SH
SOLE
3619522
0
0
THESEUS PHARMACEUTICALS INC
COM
88369M101
6837600
770000
SH
SOLE
770000
0
0
TREVI THERAPEUTICS INC
COM
89532M101
5642541
3050022
SH
SOLE
3050022
0
0
VECTIVBIO HLDG AG
ORD SHS
H9060V101
15879660
1866000
SH
SOLE
1866000
0
0
VIRIDIAN THERAPEUTICS INC
COM
92790C104
68684566
2699865
SH
SOLE
2699865
0
0